Judith M. Matthews, Chief Financial Officer at Iterum Therapeutics plc (ITRM), sold 112,260 shares at $1.64 ($184K) on 2020-09-30, disclosed to the SEC on 2020-10-02.
Open-market sale of $184k ITRM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.64 | 56,130 | $92K | 50.0% |
| 2 | $1.64 | 56,130 | $92K | 50.0% |
| Total | $1.64 avg | 112,260 | $184K | 100% |
| Filing → |
| ITRM | SELL | 2021-01-27 | $117K | — | Filing → |
| ITRM | BUY | 2018-05-30 | $52K | — | Filing → |